JMP Securities Reiterates “Market Perform” Rating for Cross Country Healthcare (NASDAQ:CCRN)

Cross Country Healthcare (NASDAQ:CCRNGet Free Report)‘s stock had its “market perform” rating reissued by stock analysts at JMP Securities in a note issued to investors on Thursday,Benzinga reports.

Several other equities research analysts have also recently weighed in on CCRN. Truist Financial boosted their price target on shares of Cross Country Healthcare from $15.00 to $18.61 and gave the stock a “hold” rating in a research report on Thursday, December 5th. William Blair downgraded Cross Country Healthcare from a “strong-buy” rating to a “hold” rating in a report on Wednesday, December 4th. StockNews.com began coverage on shares of Cross Country Healthcare in a research report on Friday, January 31st. They issued a “hold” rating for the company. Benchmark downgraded shares of Cross Country Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, December 4th. Finally, Barrington Research reaffirmed a “market perform” rating on shares of Cross Country Healthcare in a report on Tuesday, December 10th. Six analysts have rated the stock with a hold rating, According to data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $18.54.

Get Our Latest Research Report on Cross Country Healthcare

Cross Country Healthcare Stock Down 0.0 %

NASDAQ CCRN traded down $0.01 during trading hours on Thursday, reaching $18.22. The company’s stock had a trading volume of 37,147 shares, compared to its average volume of 441,474. Cross Country Healthcare has a 1 year low of $9.58 and a 1 year high of $21.41. The firm’s 50-day moving average price is $17.55 and its 200-day moving average price is $14.86. The company has a market capitalization of $597.82 million, a price-to-earnings ratio of -364.23, a PEG ratio of 3.35 and a beta of 0.44.

Institutional Trading of Cross Country Healthcare

A number of institutional investors have recently bought and sold shares of the business. Truvestments Capital LLC purchased a new stake in Cross Country Healthcare in the third quarter valued at $39,000. Plato Investment Management Ltd purchased a new stake in Cross Country Healthcare in the 4th quarter valued at $46,000. Point72 Asia Singapore Pte. Ltd. purchased a new stake in Cross Country Healthcare during the 3rd quarter valued at approximately $49,000. Point72 DIFC Ltd purchased a new position in shares of Cross Country Healthcare during the 3rd quarter worth approximately $52,000. Finally, Gladius Capital Management LP lifted its position in Cross Country Healthcare by 83.4% during the third quarter. Gladius Capital Management LP now owns 3,985 shares of the business services provider’s stock worth $54,000 after buying an additional 1,812 shares during the period. 96.03% of the stock is owned by hedge funds and other institutional investors.

About Cross Country Healthcare

(Get Free Report)

Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company’s Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.

Featured Articles

Receive News & Ratings for Cross Country Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cross Country Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.